MF Med INC

MF Med INC was paid $4.27M by Medicaid between Jan 2018 and Dec 2024, across 32 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 24% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	11,798	$570K
2019	15,333	$538K
2020	19,483	$771K
2021	24,561	$1.09M
2022	19,168	$696K
2023	8,737	$307K
2024incomplete	10,280	$303K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	24%	19,780	17,449	$1.01M
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	24%	13,191	11,298	$1.01M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	20%	25,421	22,270	$850K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	14%	14,587	13,106	$599K
64483		5.4%	1,779	1,548	$231K
64484		4.0%	1,807	1,329	$169K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	1.8%	987	955	$76K
64479		1.3%	327	280	$57K
64480		1.1%	409	289	$46K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	<1%	371	351	$38K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	5,943	1,541	$35K
99152		<1%	1,456	1,233	$32K

20 more codes

96127		<1%	9,510	$26K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	2,465	$24K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	3,193	$19K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	2,870	$11K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	1,457	$10K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	148	$8K
01992		<1%	91	$7K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	119	$6K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,539	$1K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	116	$1K
S9088	Services provided in an urgent care center (list in addition to code for service)	<1%	1,115	$912.61
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	19	$431.30
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	12	$188.15
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	45	$149.67
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	16	$135.97
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	349	$78.10
J1094	Injection, dexamethasone acetate, 1 mg	<1%	96	$8.32
J3490	Unclassified drugs	<1%	14	$7.78
99072		0%	79	$0.00
97164		0%	49	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVAN NATTA, JAMES (PRESIDENT)